Salvia Investment GmbH

CIK: 0002162499

Transaction Breakdown

Open Market Buys (P)1 (50.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

BBTX

Bambusa Therapeutics, Inc.

10% Owner

Discretionary Trading P&L

Holdings

Transaction History (2 total)

BBTX
Bambusa Therapeutics, Inc.
Nov 2, 2026
Conversion(C)
Direct
4.8M shares-
BBTX
Bambusa Therapeutics, Inc.
Nov 2, 2026
Purchase(P)
Direct
375K shares at avg. $16.00$6.0M

		Type	Shares	Price		Ownership
Nov 2, 2026	BBTX Bambusa Therapeutics, Inc.	Conversion(C)	4,769,701	-	$0	Direct
Nov 2, 2026	BBTX Bambusa Therapeutics, Inc.	Purchase(P)	375,000	$16.00	$6,000,000	Direct

1-2 of 2 transactions

About Salvia Investment GmbH

Salvia Investment GmbH (SEC CIK 0002162499) files insider reports with the SEC as 10% Owner of Bambusa Therapeutics, Inc. (BBTX).

Signal8 holds 2 ownership filings by Salvia Investment GmbH (1 Form 3, 1 Form 4), filed between Oct 29, 2026 and Nov 2, 2026. Those filings report 2 transactions, the latest on Nov 2, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Salvia Investment GmbH's filings is in HOLZKIRCHEN.

Recent filings by Salvia Investment GmbH

Nov 2, 2026: Conversion of BBTX shares (Form 4, code C).
Nov 2, 2026: Open-market purchase of BBTX shares (Form 4, code P).

Other insiders filing for Bambusa Therapeutics, Inc. (BBTX)

How to read Form 4 transaction codes